Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127672001 | 12767200 | 1 | I | 20160824 | 20160914 | 20160921 | 20160921 | EXP | CH-SM-2016-07407 | CH-009507513-1609CHE007135 | MERCK | 76.04 | YR | M | Y | 64.00000 | KG | 20160921 | MD | CH | CH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127672001 | 12767200 | 1 | PS | KEYTRUDA | PEMBROLIZUMAB | 1 | Intravenous drip | 2 MG/KG, Q3W | 125514 | 2 | MG/KG | POWDER FOR INJECTION | Q3W | ||||||
| 127672001 | 12767200 | 2 | SS | ZELBORAF | VEMURAFENIB | 1 | Oral | 240 MG, BID | 3840 | MG | N | 0 | 240 | MG | BID | ||||
| 127672001 | 12767200 | 3 | SS | PANTOPRAZOLE SODIUM. | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, QD | N | 0 | 40 | MG | QD | ||||||
| 127672001 | 12767200 | 4 | SS | ASPIRIN CARDIO | ASPIRIN | 1 | 100 MG, UNK | 0 | 100 | MG | FILM-COATED TABLET | ||||||||
| 127672001 | 12767200 | 5 | SS | RASILEZ HCT | ALISKIRENHYDROCHLOROTHIAZIDE | 1 | 300 MG, QD | N | 0 | 300 | MG | QD | |||||||
| 127672001 | 12767200 | 6 | C | AUGMENTIN | AMOXICILLINCLAVULANATE POTASSIUM | 1 | 0 | ||||||||||||
| 127672001 | 12767200 | 7 | C | ROCEPHIN | CEFTRIAXONE SODIUM | 1 | 0 | ||||||||||||
| 127672001 | 12767200 | 8 | C | PRADIF T | TAMSULOSIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127672001 | 12767200 | 9 | C | TARGIN | NALOXONE HYDROCHLORIDEOXYCODONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127672001 | 12767200 | 10 | C | ZYLORIC | ALLOPURINOL | 1 | 0 | ||||||||||||
| 127672001 | 12767200 | 11 | C | PHYSIOTENS | MOXONIDINE | 1 | 0 | FILM-COATED TABLET | |||||||||||
| 127672001 | 12767200 | 12 | C | NEBIVOLOL. | NEBIVOLOL | 1 | UNK | 0 | |||||||||||
| 127672001 | 12767200 | 13 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 0 | ||||||||||||
| 127672001 | 12767200 | 14 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | 0 | FILM-COATED TABLET | |||||||||||
| 127672001 | 12767200 | 15 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 0 | FILM-COATED TABLET | |||||||||||
| 127672001 | 12767200 | 16 | C | EZETROL | EZETIMIBE | 1 | 0 | TABLET | |||||||||||
| 127672001 | 12767200 | 17 | C | FRAGMIN | DALTEPARIN SODIUM | 1 | UNK | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127672001 | 12767200 | OT |
| 127672001 | 12767200 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127672001 | 12767200 | Acute kidney injury | |
| 127672001 | 12767200 | Renal tubular disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127672001 | 12767200 | 1 | 20160810 | 0 | ||
| 127672001 | 12767200 | 2 | 20160817 | 20160830 | 0 | |
| 127672001 | 12767200 | 3 | 20160904 | 0 | ||
| 127672001 | 12767200 | 5 | 20160904 | 0 | ||
| 127672001 | 12767200 | 6 | 20160816 | 20160817 | 0 | |
| 127672001 | 12767200 | 7 | 20160817 | 20160821 | 0 | |
| 127672001 | 12767200 | 8 | 20160823 | 20160827 | 0 | |
| 127672001 | 12767200 | 9 | 20160816 | 20160904 | 0 | |
| 127672001 | 12767200 | 10 | 20160819 | 20160827 | 0 | |
| 127672001 | 12767200 | 11 | 20160904 | 0 | ||
| 127672001 | 12767200 | 13 | 20160904 | 0 | ||
| 127672001 | 12767200 | 14 | 201609 | 0 | ||
| 127672001 | 12767200 | 15 | 20160904 | 0 | ||
| 127672001 | 12767200 | 16 | 20160904 | 0 |